Search - tctmd.com

Displaying 301 - 320 of 380

Sort: Relevancy | Date

News Features

CMS Penalties Spur Efforts to Reduce 30-Day Hospital Readmissions

July 21, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Method Chosen to Estimate Pre-PCI Kidney Function Matters

L.A. McKeown

June 29, 2015

News Industry News

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

June 22, 2015

News Industry News

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

June 18, 2015

Presentation CCVVC 2015

Data for Recent Antiplatelets and Antithrombotics

Presenter: Deepak L. Bhatt

June 17, 2015

News Daily News

Meta-analysis Supports Benefit of Complete Revascularization in STEMI

Todd Neale

June 11, 2015

News Industry News

Knowledge Gaps and Misperceptions on Impact of Atrial Fibrillation and Stroke Exist Among Patients, Caregivers and Physicians

May 13, 2015

News Daily News

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

L.A. McKeown

May 06, 2015

News Daily News

ISAR-TRIPLE 已发布：6 周与 6 个月三联疗法比较并无净收益

April 29, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

April 29, 2015

News Conference News ACC 2015

Anticoagulation With Off-Switch Fails to Improve PCI Outcomes, Sparks Allergic Reactions

Todd Neale

March 15, 2015

News Daily News

在心梗后进行抗血栓治疗的同时使用 NSAID 会增加出血、心血管事件

Yael L. Maxwell

February 25, 2015

News Daily News

El Uso Concomitante FAINE+Tratamiento Antitrombótico Aumenta las Hemorragias y los Episodios CV Post-IM

Yael L. Maxwell

February 25, 2015

News Daily News

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

Yael L. Maxwell

February 25, 2015

Presentation

Association of NSAID Use with Risk of Bleeding, CV Events in Patients Receiving Antithrombotic Therapy After MI

Presenter: Anne-Marie Schjerning Olsen

February 23, 2015

News Daily News

Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI

L.A. McKeown

February 22, 2015

News Daily News

SCAAR: Stent Thrombosis Risk After Primary PCI No Higher With Bivalirudin Than Other Antithrombotics

Todd Neale

February 19, 2015

News Daily News

New Percutaneous Device Reduces Resistant Hypertension in Small Trial

February 03, 2015

Advertisement

CMS Penalties Spur Efforts to Reduce 30-Day Hospital Readmissions

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Method Chosen to Estimate Pre-PCI Kidney Function Matters

Idarucizumab Reverses the Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

Data for Recent Antiplatelets and Antithrombotics

Meta-analysis Supports Benefit of Complete Revascularization in STEMI

Knowledge Gaps and Misperceptions on Impact of Atrial Fibrillation and Stroke Exist Among Patients, Caregivers and Physicians

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

ISAR-TRIPLE 已发布：6 周与 6 个月三联疗法比较并无净收益

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

ISAR-TRIPLE Publicado: No hay Beneficio Neto durante 6 Semanas frente a 6 Meses a Tratamiento Triple

Anticoagulation With Off-Switch Fails to Improve PCI Outcomes, Sparks Allergic Reactions

在心梗后进行抗血栓治疗的同时使用 NSAID 会增加出血、心血管事件

El Uso Concomitante FAINE+Tratamiento Antitrombótico Aumenta las Hemorragias y los Episodios CV Post-IM

Concomitant NSAID, Antithrombotic Therapy Increases Bleeding, CV Events After MI

Association of NSAID Use with Risk of Bleeding, CV Events in Patients Receiving Antithrombotic Therapy After MI

Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI

SCAAR: Stent Thrombosis Risk After Primary PCI No Higher With Bivalirudin Than Other Antithrombotics

New Percutaneous Device Reduces Resistant Hypertension in Small Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content